Details for New Drug Application (NDA): 216852
✉ Email this page to a colleague
The generic ingredient in PHYTONADIONE is phytonadione. There is one drug master file entry for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the phytonadione profile page.
Summary for 216852
| Tradename: | PHYTONADIONE |
| Applicant: | Baxter Hlthcare Corp |
| Ingredient: | phytonadione |
| Patents: | 0 |
Pharmacology for NDA: 216852
| Physiological Effect | Increased Prothrombin Activity Reversed Anticoagulation Activity |
Suppliers and Packaging for NDA: 216852
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 216852 | ANDA | Baxter Healthcare Corporation | 43066-132 | 43066-132-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (43066-132-10) / .5 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/0.5ML | ||||
| Approval Date: | Feb 26, 2026 | TE: | AB2 | RLD: | No | ||||
Complete Access Available with Subscription
